Search clinical trials for: ARAVA

Total 46 results

Brava

Completed

Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting

Mastectomy | Mammaplasty | Lumpectomy

United States
Shaare Zedek Medical Center

Unknown

Brava and Fat Transfer for Breast Reconstruction (Brava)

Fat Necrosis of Breast
Star Scientific, Inc

Completed

A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers

Smoking | Tobacco Use Disorder

United States
Sykehuset Telemark

Completed

Breast Reconstruction With Autologous Tissue: Microsurgery or Fat Grafting?

Breast Cancer | Mammaplasty

Norway
Star Scientific, Inc

Completed

A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge

Smoking | Tobacco Use Disorder

United States
Sanofi

Completed

Leflunomide in Systemic Lupus Erythematosus

Systemic Lupus Eythematosus (SLE)

Hong Kong
Star Scientific, Inc

Completed

Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers

Smoking | Tobacco Use Disorder

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

To Determine the Bioequivalence Study Under Fasting
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease | Steroid Refractory Graft Versus Host Disease

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders

Recurrent Lymphoproliferative Disorder | Refractory Lymphoproliferative Disorder

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
Joseph Sparano

Recruiting

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Breast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Roswell Park Cancer Institute

Terminated

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

Tobacco Use Disorder

United States
University of Minnesota
National Cancer Institute (NCI)

Completed

Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers

Tobacco Use Disorder

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets Under Fasting Conditions

Healthy

United States
Sanofi

Completed

Leflunomide + Methotrexate in Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Smoldering Plasma Cell Myeloma

United States
Shanghai Zhongshan Hospital

Recruiting

The Registry Study of Takayasu Arteritis in East China

Pregnancy Related | Takayasu Arteritis | Treatment Refusal | Outcome | Mechanisms, Defense

China
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

Smoldering Plasma Cell Myeloma

United States
Mashhad University of Medical Sciences

Unknown

Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis (JIA)

Juvenile Idiopathic Arthritis

Iran, Islamic Republic of
Sandoz

Completed

To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions

Rheumatoid Arthritis | Psoriatic Arthritis
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
International Bio service

Not yet recruiting

Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions

Healthy Volunteer
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Smoldering Plasma Cell Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Acute Graft Versus Host Disease | Hematopoietic and Lymphoid System Neoplasm

United States
Shenzhen Second People's Hospital

Unknown

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Renal Insufficiency, Chronic | Glomerulonephritis, IGA

China
Chinese PLA General Hospital

Completed

Leflunomide for Maintenance of Remission in IgG4 Related Disease

Immunoglobulin G4 Related Sclerosing Disease

China
University of Oklahoma

Completed

Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure (EZI)

Secondhand Smoke

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Recurrent Glioblastoma | IDH Family Wildtype | Recurrent Anaplastic Astrocytoma

United States
P. Verschueren
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.

Rheumatoid Arthritis

Belgium
University of Nebraska

Completed

Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Jawaharlal Institute of Postgraduate Medical Education...

Completed

Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis

Rheumatoid Arthritis

India
Jawaharlal Institute of Postgraduate Medical Education...

Terminated

Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy

Rheumatoid Arthritis

India
Emory University
National Cancer Institute (NCI)

Withdrawn

Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

Recurrent Glioblastoma | Recurrent Gliosarcoma
University of Nebraska

Recruiting

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Rheumatoid Arthritis

United States
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Glioblastoma | Gliosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Glioblastoma | Gliosarcoma | Anaplastic Astrocytoma | Central Nervous System Neoplasm | Spinal Cord Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
University of Erlangen-Nürnberg Medical School

Recruiting

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Psoriatic Arthritis | Withdrawal | Reduction

Germany
National Cancer Institute (NCI)

Not yet recruiting

Anti-Lag-3 (Relatlinib) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Recurrent Glioblastoma
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Untreated Childhood Medulloblastoma

United States, Canada, Australia, New Zealand, Switzerland, Netherlands
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

Medulloblastoma

United States, Canada, Saudi Arabia, Puerto Rico, Australia
Children's Oncology Group
National Cancer Institute (NCI)

Suspended

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Medulloblastoma

United States

Search clinical trials for: ARAVA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations